Marvell ® Teralynx ® 10 switch now available in Linux Foundation's open-source SONiC, capitalizing on market shift to open network platforms SANTA CLARA, Calif., July 25, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced the immediate availability of the Marvell® Teralynx® 10 51.2 Tbps Ethernet switch device in the Linux Foundation's SONiC (Software for Open Networking in the Cloud) network operating system. With this publi ...

Marvel Announces an Extension to Its Collaboration with The iBraiN Institute to Test MB204 In a Pre-Clinical Model of Rett SyndromeJuly 24, 2024 9:00 AM EDT | Source: Marvel Biosciences Corp.Calgary, Alberta--(Newsfile Corp. - July 24, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), today is pleased to announce the extension of its collaboration with Drs. Julie Le Merrer and Jerom ...

文章核心观点 - 华尔街分析师的推荐常被投资者用于决定买入、卖出或持有股票,但这些推荐的可靠性存在争议 [1] - 马维尔科技(MRVL)目前的平均券商评级(ABR)为1.14,介于强烈买入和买入之间 [3] - 券商推荐存在积极偏差,不能完全反映股票未来价格走势,需要结合其他分析工具进行判断 [5][6][7] 根据相关目录分别进行总结 券商推荐的局限性 - 券商分析师由于自身利益关系,倾向于给予股票积极的评级,这与普通投资者的利益并不完全一致 [6][7] - 券商推荐很难准确预测股票未来价格走势,不应过度依赖 [5][7] 与Zacks评级的对比 - Zacks评级是基于盈利预测修正的量化模型,更能反映股票未来表现 [8][12][13] - Zacks评级与券商ABR不同,前者更新及时,后者可能存在滞后 [14] 马维尔科技的投资评级 - 马维尔目前的Zacks评级为3级(中性),与券商的买入评级存在差异 [15][16][17] - 分析师对公司盈利前景持稳定态度,短期内公司表现可能与大盘持平 [15][16]

Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has closed its non-brokered private placement unit offering (the "Offering"). The offering resulted in the issuance of 5,000,000 units at $0.10 per unit (the "Units") for gross proceeds of $500,000. Each Unit is comprised of ...

文章核心观点 - 公司的数据中心市场收入大幅增长,达到历史新高,这与超大规模数据中心客户减少对昂贵的英伟达芯片的依赖,转而自主设计AI芯片的趋势相吻合 [5][6] - 公司的AI定制芯片市场份额有望从目前的10%提升至20% [9] - 公司已经成功获得第三家超大规模数据中心客户,这是一个重要里程碑 [10] - 公司的估值目前被市场低估,有24-25%的上涨空间 [13] 根据目录分类总结 数据中心市场 - 公司数据中心市场收入大幅增长,达到历史新高 [5] - 这与超大规模数据中心客户减少对昂贵的英伟达芯片的依赖,转而自主设计AI芯片的趋势相吻合 [6] - 公司的AI定制芯片市场份额有望从目前的10%提升至20% [9] - 公司已经成功获得第三家超大规模数据中心客户,这是一个重要里程碑 [10] 财务表现 - 公司预计下半年出货量将大幅增加,带动收入增长13-15% [11] - 未来3年公司营业利润有望保持20%左右的复合年增长率 [12] 估值分析 - 公司当前估值被市场低估,有24-25%的上涨空间 [13]

Marvell has all the pieces in place to rival the best AI chip designers, but it's underperforming nonetheless.After a solid rally in 2023 and a hot start to 2024, shares of chip designer Marvell Technology Group (MRVL 1.57%) have failed to participate in the artificial intelligence (AI) chip stock surge this year. It's a confounding situation, because Marvell has many of the pieces in place to rival one of the top semiconductor stocks right now, Broadcom (AVGO 2.20%). Is there something wrong with Marvell? ...

Marvell Technology (MRVL) shares have climbed 14% year to date, reflecting investors’ confidence in the company’s strong financials and innovative product line.MRVL is benefiting from robust demand across its electro-optics portfolio, which includes pulse amplitude modulation (“PAM”), digital signal processors (“DSP”), trans-impedance amplifiers and ZR data center interconnect products.Adding to its wide array of electro-optics portfolio, Marvell Technology has launched the Alaska A 1.6T PAM4 DSP for active ...

New Alaska® A 1.6T PAM4 DSP for copper interconnects is built on Marvell industry-leading 5nm PAM4 technology. Addresses the growing need for 200G/lane I/O to handle AI accelerator and GPU bandwidth demands.  Enables 1.6T short-reach copper connectivity within accelerated compute racks. SANTA CLARA, Calif., June 27, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today introduced the Marvell® Alaska® A 1.6T PAM4 DSP for active electric ...

SANTA CLARA, Calif., June 21, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on July 31, 2024 to shareholders of record as of July 12, 2024.About MarvellTo deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for over 25 years, we move, store, process and ...

Calgary, Alberta--(Newsfile Corp. - June 21, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), wishes to announce that, further to Marvel's May 16, 2024 press release announcing the Company's non-brokered private placement unit offering (the "Offering"), the TSX Venture Exchange ("TSXV" or the "Exchange") has conditionally accepted the Company's proposed Offering and has granted the Company a two-week extension ...